BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, April 17, 2026
Home
»
Topics
»
Disease categories and therapies
» Cancer
Cancer
RSS
NanoCarrier and Kowa to enter worldwide agreement for NC-6300
Sep. 30, 2011
YM BioSciences starts phase II trial of CYT-387 in myelofibrosis
Sep. 30, 2011
Onyx Pharmaceuticals completes carfilzomib NDA submission
Sep. 29, 2011
Cell Therapeutics completes assessment required for pixantrone NDA
Sep. 29, 2011
FDA accepts Talon Therapeutics' Marqibo NDA for filing
Sep. 29, 2011
Enrollment completed in Rexahn Pharmaceuticals' phase II Archexin trial
Sep. 29, 2011
Novel protein kinase inhibitors for cancer claimed by OSI
Sep. 29, 2011
Treatment begins in phase III PI-88 study
Sep. 29, 2011
Sunesis begins phase I trial of MLN-2480
Sep. 29, 2011
Riemser Arzneimittel receives German license for CINV combination therapy
Sep. 29, 2011
Previous
1
2
…
2448
2449
2450
2451
2452
2453
2454
2455
2456
…
4102
4103
Next
RSS